Skip to main content

Immfinity Biotechnologies

Immfinity's technology platform utilizes advanced algorithms to identify and optimize therapeutic T-cell receptors, significantly reducing the risks associated with their development. This approach accelerates the creation of targeted immunotherapies for cancer treatment, addressing the lengthy and uncertain process of T-cell receptor engineering.

Traction –/10
Vancouver, Canada · HQ
2300+ followers
  • Biotechnology
Updated 5 months ago

Funding

Funding rounds are not available yet.

Founders

2 founders

Govinda Sharma

Founder

James Round

Founder

Product

Features

  • Immfinity's technology platform utilizes advanced algorithms to identify and optimize therapeutic T-cell receptors, significantly reducing the risks associated with their development. This approach accelerates the creation of targeted immunotherapies for cancer treatment, addressing the lengthy and uncertain process of T-cell receptor engineering.
This profile is AI-generated and may contain inaccuracies.